Literature DB >> 8666495

Blood pressure and cancer in middle-aged British men.

G Wannamethee1, A G Shaper.   

Abstract

BACKGROUND: This paper examines the relationship between blood pressure and cancer mortality.
METHODS: A prospective study of 7735 middle-aged men drawn at random from one general practice in each of 24 British towns.
RESULTS: During a mean follow-up period of 12.75 years there were 351 deaths from cancers. The relationship between blood pressure and cancer differed with respect to follow-up period. In the first 5 years of follow-up, a significant inverse relationship was seen between systolic (SBP) and diastolic blood pressure (DBP) and cancer mortality even after adjustment for age, smoking, social class, physical activity, alcohol intake, body mass index, diabetes, pre-existing ischaemic heart disease, use of antihypertensive drugs, cholesterol, heart rate and serum albumin. In the subsequent follow-up period (5.1-12.75 years) a significant positive association was seen between SBP (but not DBP) and risk of cancer mortality, even after adjustment for the other risk factors. Men in the top fifth of SBP ( > or = 161 mmHg) showed over a 50% increase in risk of cancer mortality compared to men in the bottom quintile (RR = 1.56 95% CI 95% CI: 1.04-2.38). This positive relationship between SBP and cancer was seen only in current cigarette smokers. Use of antihypertensive drugs was not associated with cancer mortality.
CONCLUSION: The association of elevated SBP with increased risk of cancer mortality seen only in current smokers warrants the search for factors which affect SBP, interact with smoking and are potentially carcinogenic.

Entities:  

Mesh:

Year:  1996        PMID: 8666495     DOI: 10.1093/ije/25.1.22

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

Review 1.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 2.  Critical review of cancer risk associated with angiotensin receptor blocker therapy.

Authors:  Grégoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Vasc Health Risk Manag       Date:  2011-12-12

3.  Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study.

Authors:  Fabrizio Dal Moro; Alberto Bovo; Alessandro Crestani; Roberto Vettor; Marina P Gardiman; Filiberto Zattoni
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

4.  Hypertension and subsequent genitourinary and gynecologic cancers risk: a population-based cohort study.

Authors:  Li-Min Sun; Huang-Tsung Kuo; Long-Bin Jeng; Cheng-Li Lin; Ji-An Liang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  Associations of mortality with own blood pressure using son's blood pressure as an instrumental variable.

Authors:  David Carslake; Abigail Fraser; Margaret T May; Tom Palmer; Karri Silventoinen; Per Tynelius; Debbie A Lawlor; George Davey Smith
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

6.  Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study.

Authors:  G D Batty; M J Shipley; M G Marmot; G Davey Smith
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

7.  Association of perioperative blood pressure with long-term survival in rectal cancer patients.

Authors:  Hui-Chuan Yu; Yan-Xin Luo; Hui Peng; Xiao-Lin Wang; Zi-Huan Yang; Mei-Jin Huang; Liang Kang; Lei Wang; Jian-Ping Wang
Journal:  Chin J Cancer       Date:  2016-04-11

8.  The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population.

Authors:  Nan Sha; Hao Xu; Tao Chen; Da-Wei Tian; Wan-Qin Xie; Lin-Guo Xie; Yu Zhang; Chen Xing; Xiao-Teng Liu; Zhong-Hua Shen; Zhou-Liang Wu; Hai-Long Hu; Chang-Li Wu
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

9.  Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.

Authors:  Dechao Feng; Pan Song; Yubo Yang; Wuran Wei; Li Li
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.